Positive Affect Treatment Outperforms Negative Affect Treatment in Depression, Anxiety
Medically reviewed by Drugs.com
via HealthDayFRIDAY, May 1, 2026 -- Positive affect treatment (PAT) engaging reward systems yields a greater improvement on clinical status than negative affect treatment (NAT) for adults with severely low positive affect and moderate-to-severe depression or anxiety, according to a study published online April 24 in JAMA Network Open.
Alicia E. Meuret, Ph.D., from the Southern Methodist University in Dallas, and colleagues conducted a two-arm randomized clinical superiority trial involving treatment-seeking adults with severely low positive affect and moderate-to-severe depression or anxiety that was functionally impairing. Participants underwent 15 weekly individual therapy sessions of PAT or NAT (51 and 47 patients, respectively).
The researchers found that in analyses of the three clinical status variables as a multivariate outcome (self-reported positive affect, interviewer-rated anhedonia, and self-reported depression and anxiety), clinical status improved more with PAT than NAT, and better (higher) scores on clinical status were seen with PAT than NAT at the one-month follow-up. PAT and NAT had comparable improvement in reward anticipation-motivation and reward attainment targets. Six of seven reward and threat self-reported target measures mediated improvements in clinical status, but behavioral and psychological measures did not.
"There's a difference between feeling helpless and feeling hopeless," Meuret said in a statement. "When you feel helpless, you still have the drive and the will to want to change things. When people feel hopeless, they don't believe anything will change. That's what anhedonia can look like, and taking away negative emotions doesn't fix it."
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
Source: HealthDay
Posted : 2026-05-02 09:24
Read more
- CMS Extends Medicare's Short-Term Bridge Program for GLP-1 Obesity Drug Coverage
- Physical Therapy May Be Beneficial for Chronic Low Back Pain
- Jasmine Rice Recalled Nationwide Over Possible Contamination
- Wegovy Pill Demonstrated Greater Weight Loss Than Orforglipron and Lower Odds of Stopping Medication Due to Side Effects in a New Indirect Comparison to be Presented at Obesity Medicine Association 2026
- Moderna Starts Large Bird Flu Study Despite Earlier HHS Funding Loss
- Pooled Umbilical Cord Blood Boosts Stem Cell Transplant Success, Trial Finds
Disclaimer
Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.
The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Popular Keywords
- metformin obat apa
- alahan panjang
- glimepiride obat apa
- takikardia adalah
- erau ernie
- pradiabetes
- besar88
- atrofi adalah
- kutu anjing
- trakeostomi
- mayzent pi
- enbrel auto injector not working
- enbrel interactions
- lenvima life expectancy
- leqvio pi
- what is lenvima
- lenvima pi
- empagliflozin-linagliptin
- encourage foundation for enbrel
- qulipta drug interactions